1d
The Weather Channel on MSNManaging Eczema Symptoms: Indoor And Outdoor Environments Have Different TriggersSign up for the Morning Brief email newsletter to get weekday updates from The Weather Channel and our meteorologists.If you ...
In this Q&A, Marty Becker, DVM, Elite FFCP-V and Paul Bloom, DVM, DACVD, DABVP (Canine and Feline), Elite FFCP-III share ...
For children with atopic dermatitis (AD), early childhood stressful life events are associated with an increased risk for disease activity, according to a study published online Jan. 28 in the Journal ...
Panelists discuss how the data from the BRAVE-AA1 and BRAVE-AA2 phase 3 trials demonstrated the safety and efficacy of baricitinib, leading to its FDA approval in 2022 as the first systemic treatment ...
The global atopic dermatitis treatment market is on the cusp of remarkable expansion, with projections indicating a surge in ...
As temperatures drop, many people experience dry, red, and itchy skin, a condition that often worsens in winter.
The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used as a standalone treatment for patients with severe depression ...
A pioneering new treatment promises to tackle a wider range of cancers, with fewer side-effects than conventional radiotherapy. It also takes less than a second. In a series of vast underground ...
They outline the importance of understanding care access through this lens as various patient barriers, such as travel time for emergency care, remain ill-understood and understudied. Data were ga ...
This achievement further underlines the drug’s efficacy across multiple indications, including atopic dermatitis (AD ... in shaping a more competitive treatment landscape for AD and bolster ...
The Rafah crossing is expected to open as part of the deal, allowing Palestinians in Gaza to leave for medical treatment. The territory’s healthcare sector has been ravaged by the war ...
‘The #atopic_dermatitis market is heating up! #Sanofi is gearing up to challenge #Dupixent's dominance. What new treatments are on the horizon?’ Sanofi is also advancing in the AD arena with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results